Back to Alzheimers Disease
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT01450891

NCT01450891
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You are a new patient at one of the participating memory clinics and doctors suspect you may have a brain condition affecting memory or thinking.
  • You have memory concerns, whether noticed only by yourself or confirmed through testing.
  • Your level of daily functioning and memory falls within a specific range measured by a standard assessment called the CDR (score of 0, 0.5, or 1) (confirm with trial site).
  • You scored 20 or higher on a standard memory and thinking test called the MMSE (confirm with trial site).
  • You have a trusted family member, friend, or carer who sees you or speaks with you at least once a week.

Who may not be able to join:

  • You have been diagnosed with Normal Pressure Hydrocephalus (a condition involving fluid build-up in the brain) (confirm with trial site).
  • You have been diagnosed with Huntington's disease.
  • You have had a mini-stroke or stroke in the past 2 years, or a mini-stroke or stroke that caused memory or thinking problems within the past 3 months.
  • You have been diagnosed with schizophrenia or another psychotic disorder within the past 12 months.
  • You have experienced major depression within the past 12 months.
  • You have a problem with alcohol misuse.
  • You have a brain tumour, epilepsy, or have had brain inflammation (encephalitis).
  • You do not have a reliable person who can act as an informant for the study.
  • You are unlikely to be able to attend follow-up appointments.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Maastricht University Medical Center
Registry
clinicaltrials_gov
Start date
1 September 2009
Est. completion
1 July 2013

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Diagnostic accuracy of Magnetic Resonance Imaging (MRI); Change in cognition at 2 years; Change in dementia severity at 2 years; Change in quality of life at 2 years; Health care resource use during 2 years; Change in productivity at 2 years; Diagnostic accuracy of cerebrospinal fluid (CSF)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov